Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 69

    1.

    Comparison of vildagliptin and thiazolidinedione as add-on therapy in patients inadequately controlled with metformin: results of the GALIANT trial--a primary care, type 2 diabetes study.

    Blonde L, Dagogo-Jack S, Banerji MA, Pratley RE, Marcellari A, Braceras R, Purkayastha D, Baron M.

    Diabetes Obes Metab. 2009 Oct;11(10):978-86. Epub 2009 Jul 13.PMID: 19614942 [PubMed - in process]Related articles

    2.

    Glucoregulatory physiology in subjects with low-normal, high-normal, or impaired fasting glucose.

    Dagogo-Jack S, Askari H, Tykodi G.

    J Clin Endocrinol Metab. 2009 Jun;94(6):2031-6. Epub 2009 Mar 10.PMID: 19276238 [PubMed - indexed for MEDLINE]Related articles

    3.

    Iodine deficiency disorders in the iodine-replete environment.

    Nyenwe EA, Dagogo-Jack S.

    Am J Med Sci. 2009 Jan;337(1):37-40.PMID: 19155752 [PubMed - indexed for MEDLINE]Related articles

    4.

    The role of antipsychotic agents in the development of diabetes mellitus.

    Dagogo-Jack S.

    Nat Clin Pract Endocrinol Metab. 2009 Jan;5(1):22-3. Epub 2008 Oct 28. No abstract available. PMID: 18957954 [PubMed - indexed for MEDLINE]Related articles

    5.

    Dynamic responses to leptin secretagogues in lean, obese, and massively obese men and women.

    Dagogo-Jack S, Askari H, Tykodi G, Liu J, Umamaheswaran I.

    Horm Res. 2008;70(3):174-81. Epub 2008 Jul 29.PMID: 18663318 [PubMed - indexed for MEDLINE]Related articles

    6.

    HIV therapy and diabetes risk.

    Dagogo-Jack S.

    Diabetes Care. 2008 Jun;31(6):1267-8. No abstract available. PMID: 18509145 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program.

    Perreault L, Ma Y, Dagogo-Jack S, Horton E, Marrero D, Crandall J, Barrett-Connor E; Diabetes Prevention Program.

    Diabetes Care. 2008 Jul;31(7):1416-21. Epub 2008 Mar 20.PMID: 18356403 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Barriers to achieving optimal glycemic control in a multi-ethnic society: a US focus.

    Dagogo-Jack S, Funnell MM, Davidson J.

    Curr Diabetes Rev. 2006 Aug;2(3):285-93. Review.PMID: 18220633 [PubMed - indexed for MEDLINE]Related articles

    9.

    Therapy insight: metabolic and endocrine disorders in sickle cell disease.

    Smiley D, Dagogo-Jack S, Umpierrez G.

    Nat Clin Pract Endocrinol Metab. 2008 Feb;4(2):102-9. Review.PMID: 18212812 [PubMed - indexed for MEDLINE]Related articles

    10.

    Recognizing iodine deficiency in iodine-replete environments.

    Nyenwe EA, Dagogo-Jack S.

    N Engl J Med. 2007 Sep 20;357(12):1263-4. No abstract available. PMID: 17881763 [PubMed - indexed for MEDLINE]Related articles

    11.

    The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes.

    Diabetes Prevention Program Research Group, Crandall J, Schade D, Ma Y, Fujimoto WY, Barrett-Connor E, Fowler S, Dagogo-Jack S, Andres R.

    J Gerontol A Biol Sci Med Sci. 2006 Oct;61(10):1075-81.PMID: 17077202 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Role of thiazolidinediones in the management of type 2 diabetes: focus on ethnic minority populations.

    Umpierrez G, Dagogo-Jack S.

    Ethn Dis. 2006 Winter;16(1):51-7.PMID: 16599348 [PubMed - indexed for MEDLINE]Related articles

    13.

    Primary prevention of type-2 diabetes in developing countries.

    Dagogo-Jack S.

    J Natl Med Assoc. 2006 Mar;98(3):415-9. Review.PMID: 16573308 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Epidemiology of type 2 diabetes: focus on ethnic minorities.

    Egede LE, Dagogo-Jack S.

    Med Clin North Am. 2005 Sep;89(5):949-75, viii. Review.PMID: 16129107 [PubMed - indexed for MEDLINE]Related articles

    15.

    Energy adaptation to glucocorticoid-induced hyperleptinemia in human beings.

    Askari H, Liu J, Dagogo-Jack S.

    Metabolism. 2005 Jul;54(7):876-80.PMID: 15988695 [PubMed - indexed for MEDLINE]Related articles

    16.

    Inhibition of cortisol biosynthesis decreases circulating leptin levels in obese humans.

    Dagogo-Jack S, Tykodi G, Umamaheswaran I.

    J Clin Endocrinol Metab. 2005 Sep;90(9):5333-5. Epub 2005 Jun 28.PMID: 15985478 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Primary prevention of cardiovascular disease in pre-diabetes: the glass is half full and half empty.

    Dagogo-Jack S.

    Diabetes Care. 2005 Apr;28(4):971-2. Review. No abstract available. PMID: 15793208 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Hypoglycemia in type 1 diabetes mellitus: pathophysiology and prevention.

    Dagogo-Jack S.

    Treat Endocrinol. 2004;3(2):91-103. Review.PMID: 15743105 [PubMed - indexed for MEDLINE]Related articles

    19.

    Tumor-grade hyperprolactinemia induced by multiple medications in the setting of renal failure.

    Ziambaras K, Dagogo-Jack S.

    Endocr Pract. 1999 May-Jun;5(3):139-42.PMID: 15251686 [PubMed]Related articles

    20.

    QSource quality initiative. Reversing the diabetes epidemic in Tennessee.

    Bailey JE, Gibson DV, Jain M, Connelly SA, Ryder KM, Dagogo-Jack S.

    Tenn Med. 2003 Dec;96(12):559-63.PMID: 15077562 [PubMed - indexed for MEDLINE]Related articles

    21.

    Ethnic disparities in type 2 diabetes: pathophysiology and implications for prevention and management.

    Dagogo-Jack S.

    J Natl Med Assoc. 2003 Sep;95(9):774, 779-89. Review.PMID: 14527045 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Impact of an intramural competition on outcome of diabetes care.

    Dagogo-Jack S.

    Diabetes Care. 2003 Mar;26(3):950-1. No abstract available. PMID: 12610066 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Leptin response to glucocorticoid occurs at physiological doses and is abolished by fasting.

    Dagogo-Jack S, Umamaheswaran I, Askari H, Tykodi G.

    Obes Res. 2003 Feb;11(2):232-7.PMID: 12582219 [PubMed - indexed for MEDLINE]Related articles

    24.

    Preventing diabetes-related morbidity and mortality in the primary care setting.

    Dagogo-Jack S.

    J Natl Med Assoc. 2002 Jul;94(7):549-60. Review.PMID: 12126280 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Multiple drug targets in the management of type 2 diabetes.

    Moneva MH, Dagogo-Jack S.

    Curr Drug Targets. 2002 Jun;3(3):203-21. Review.PMID: 12041735 [PubMed - indexed for MEDLINE]Related articles

    26.

    Human leptin regulation and promise in pharmacotherapy.

    Dagogo-Jack S.

    Curr Drug Targets. 2001 Jun;2(2):181-95. Review.PMID: 11469718 [PubMed - indexed for MEDLINE]Related articles

    27.

    Physiological responses during hypoglycaemia induced by regular human insulin or a novel human analogue, insulin glargine.

    Dagogo-Jack S, Askari H, Morrill B, Lehner LL, Kim B, Sha X.

    Diabetes Obes Metab. 2000 Dec;2(6):373-83.PMID: 11225967 [PubMed - indexed for MEDLINE]Related articles

    28.

    Impaired leptin response to glucocorticoid as a chronic complication of diabetes.

    Dagogo-Jack S, Liu J, Askari H, Tykodi G, Umamaheswaran I.

    J Diabetes Complications. 2000 Nov-Dec;14(6):327-32.PMID: 11120457 [PubMed - indexed for MEDLINE]Related articles

    29.

    Hormonal regulation of human leptin in vivo: effects of hydrocortisone and insulin.

    Askari H, Liu J, Dagogo-Jack S.

    Int J Obes Relat Metab Disord. 2000 Oct;24(10):1254-9.PMID: 11093285 [PubMed - indexed for MEDLINE]Related articles

    30.

    Thyroid function during pregnancy.

    Fantz CR, Dagogo-Jack S, Ladenson JH, Gronowski AM.

    Clin Chem. 1999 Dec;45(12):2250-8. Review.PMID: 10585360 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Basal and stimulated plasma leptin in diabetic subjects.

    Liu J, Askari H, Dagogo-Jack S.

    Obes Res. 1999 Nov;7(6):537-44.PMID: 10574511 [PubMed - indexed for MEDLINE]Related articles

    32.

    Insulin resistance in HIV protease inhibitor-associated diabetes.

    Yarasheski KE, Tebas P, Sigmund C, Dagogo-Jack S, Bohrer A, Turk J, Halban PA, Cryer PE, Powderly WG.

    J Acquir Immune Defic Syndr. 1999 Jul 1;21(3):209-16.PMID: 10421244 [PubMed - indexed for MEDLINE]Related articles

    33.

    Durable reversal of hypoglycemia unawareness in type 1 diabetes.

    Dagogo-Jack S, Fanelli CG, Cryer PE.

    Diabetes Care. 1999 May;22(5):866-7. No abstract available. PMID: 10332708 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Leptin elimination in hyperleptinaemic peritoneal dialysis patients.

    Landt M, Parvin CA, Dagogo-Jack S, Bryant B, Coyne DW.

    Nephrol Dial Transplant. 1999 Mar;14(3):732-7.PMID: 10193829 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Reproducibility of fasting plasma leptin concentration in lean and obese humans.

    Liu J, Askari H, Dagogo-Jack S.

    Endocr Res. 1999 Feb;25(1):1-10.PMID: 10098588 [PubMed - indexed for MEDLINE]Related articles

    36.

    High-flux dialysis lowers plasma leptin concentration in chronic dialysis patients.

    Coyne DW, Dagogo-Jack S, Klein S, Merabet E, Audrain J, Landt M.

    Am J Kidney Dis. 1998 Dec;32(6):1031-5.PMID: 9856520 [PubMed - indexed for MEDLINE]Related articles

    37.

    Recombinant human insulin-like growth factor-I (IGF-I) therapy decreases plasma leptin concentration in patients with chronic renal insufficiency.

    Dagogo-Jack S, Franklin SC, Vijayan A, Liu J, Askari H, Miller SB.

    Int J Obes Relat Metab Disord. 1998 Nov;22(11):1110-5.PMID: 9822950 [PubMed - indexed for MEDLINE]Related articles

    38.

    Dose-dependent cortisol-induced increases in plasma leptin concentration in healthy humans.

    Newcomer JW, Selke G, Melson AK, Gross J, Vogler GP, Dagogo-Jack S.

    Arch Gen Psychiatry. 1998 Nov;55(11):995-1000.PMID: 9819068 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Hyperleptinaemia of end-stage renal disease is corrected by renal transplantation.

    Landt M, Brennan DC, Parvin CA, Flavin KS, Dagogo-Jack S, Coyne DW.

    Nephrol Dial Transplant. 1998 Sep;13(9):2271-5.PMID: 9761508 [PubMed - indexed for MEDLINE]Related articlesFree article

    40.

    Uremic hyperleptinemia: adaptive or maladaptive?

    Dagogo-Jack S.

    Kidney Int. 1998 Sep;54(3):997-8. No abstract available. PMID: 9734630 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Hyperleptinemia in patients with end-stage renal disease undergoing continuous ambulatory peritoneal dialysis.

    Dagogo-Jack S, Ovalle F, Landt M, Gearing B, Coyne DW.

    Perit Dial Int. 1998 Jan-Feb;18(1):34-40.PMID: 9527027 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Whole body leptin kinetics and renal metabolism in vivo.

    Zeng J, Patterson BW, Klein S, Martin DR, Dagogo-Jack S, Kohrt WM, Miller SB, Landt M.

    Am J Physiol. 1997 Dec;273(6 Pt 1):E1102-6.PMID: 9435524 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Reversible muscle weakness in patients with vitamin D deficiency.

    Ziambaras K, Dagogo-Jack S.

    West J Med. 1997 Dec;167(6):435-9. No abstract available. PMID: 9426489 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Robust leptin secretory responses to dexamethasone in obese subjects.

    Dagogo-Jack S, Selke G, Melson AK, Newcomer JW.

    J Clin Endocrinol Metab. 1997 Oct;82(10):3230-3.PMID: 9329344 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions.

    Dagogo-Jack S, Santiago JV.

    Arch Intern Med. 1997 Sep 8;157(16):1802-17. Review.PMID: 9290539 [PubMed - indexed for MEDLINE]Related articles

    46.

    Augmentation of bone mineral density in hirsute women.

    Dagogo-Jack S, al-Ali N, Qurttom M.

    J Clin Endocrinol Metab. 1997 Sep;82(9):2821-5.PMID: 9284703 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Increased plasma leptin concentration in end-stage renal disease.

    Merabet E, Dagogo-Jack S, Coyne DW, Klein S, Santiago JV, Hmiel SP, Landt M.

    J Clin Endocrinol Metab. 1997 Mar;82(3):847-50.PMID: 9062494 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Plasma leptin and insulin relationships in obese and nonobese humans.

    Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M.

    Diabetes. 1996 May;45(5):695-8.PMID: 8621026 [PubMed - indexed for MEDLINE]Related articles

    49.

    Memory improvement following induced hyperinsulinemia in Alzheimer's disease.

    Craft S, Newcomer J, Kanne S, Dagogo-Jack S, Cryer P, Sheline Y, Luby J, Dagogo-Jack A, Alderson A.

    Neurobiol Aging. 1996 Jan-Feb;17(1):123-30.PMID: 8786794 [PubMed - indexed for MEDLINE]Related articles

    50.

    Cerebral transport and metabolism of 1-11C-D-glucose during stepped hypoglycemia.

    Powers WJ, Dagogo-Jack S, Markham J, Larson KB, Dence CS.

    Ann Neurol. 1995 Oct;38(4):599-609.PMID: 7574456 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...